SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Deepstributed
Deepstributed Spółka z Ograniczoną Odpowiedzialnością
Deepstributed Spółka z Ograniczoną Odpowiedzialnością (KRS 0000758809, NIP 8943135255) is a Polish company, headquartered in Wrocław, Dolnośląskie voivodeship. DEEPSTRIBUTED operates in: Other research and experimental development on natural sciences and engineering (PKD 72.19.Z). Industry: Research and development. The company has been listed in the National Court Register since November 21, 2018. DEEPSTRIBUTED's most recently reported net revenue was 13.8 K PLN for 2024. DEEPSTRIBUTED's operations are currently suspended.
The company is currently suspended
Suspended since May 28, 2025
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
72.19.ZOther research and experimental development on natural sciences and engineering
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Credibility rating
5 / 100
Very poor credibility
Insolvency risk
suspended
Significant formal threat
Closure risk
80
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/7 yrs
Board changes
0
0/7 yrs
PKD changes
2
2/7 yrs
Name changes
0
0/7 yrs
Data from 7 years of registry activity.
Payment reliability score from 2019–2024
Current: S (5/100)
Trend: stable (0.0 pts/year)
Spółka jest obecnie zawieszona – działalność operacyjna wstrzymana, wskaźnik wiarygodności odzwierciedla stan przed zawieszeniem.
Standard limit from 2019–2024
Current: 164.22 PLN
Safe: 28.74 PLN
Founded
November 21, 2018
7 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WROCŁAW
DOLNOŚLĄSKIE
Primary PKD
72.19.Z
Other research and experimental development on natural sciences and…
Share capital
8.3 K PLN
Shareholders
2
shareholders
Board
1 person
Filed years
6 years
2019–2024 · profitable: 2/6
Registry entries
26
latest: June 30, 2025
Risk signals
Revenue
13.8 K PLN
2024
Net profit
-100.0 K PLN
2024
Assets
259.6 K PLN
2024
Equity
50.9 K PLN
2024
EBITDA
18.7 K PLN
2024
Valuation
0 PLN
suspended
Projects co-financed by the European Union for Deepstributed - total value, EU contribution and the company's largest awards.
Projects
1
EU co-financing
2.5 M PLN
Total project value
3.2 M PLN
Eligible spending
3.2 M PLN
Funds
Operational programmes
Top 1 by EU co-financing
| Project | Fund | EU co-financing | Value | Rate | Period |
|---|---|---|---|---|---|
Opracowanie innowacyjnego narzędzia do automatyzacji i optymalizacji doboru zasobów obliczeniowych na potrzeby przeprowadzania eksperymentów uczenia maszynowego |
Rate business credibility - Deepstributed.
No ratings
News
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase regarding BCX-CM-J - Europe's first veterinary cell-therapy drug from mesenchymal stem cells for dogs with osteoarthritis. Responses to the final EMA questions are due in May 2026; the CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. Pre-commercial biotech: 2024 closed with a PLN 14.9 m loss on zero revenue; cash of PLN 33.6 m at year-end. Trigon DM maintained a buy rating with a price target of PLN 127.2.
News
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) - a pre-commercial biotech specialising in TPD (Targeted Protein Degradation) - closed Q3 2025 with PLN 36 m of cash and grants securing financing to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I - the first patient dosed at Barcelona Clinic Liver Cancer. CT-03 (MCL-1 degrader) nearing clinical entry. Without a new R&D partnership or equity issuance in 2026, the company will need additional financing.
| EFRR |
| 2.5 M PLN |
| 3.2 M PLN |
| 77% |
| 2021–2023 |
Competing companies or those operating in the same market segment as Deepstributed (in Wrocław, industry: Research and development).
WROCŁAW· Research and development
Revenue 2024: 83.2 M PLN
WROCŁAW· Research and development
Revenue 2024: 31.7 M PLN
WROCŁAW· Research and development
Revenue 2025: 31.6 M PLN
WROCŁAW· Research and development
Revenue 2024: 16.3 M PLN
WROCŁAW· Research and development
Revenue 2025: 15.6 M PLN
WROCŁAW· Research and development
Revenue 2024: 12.0 M PLN
20 historical registry entries for Deepstributed
Filing documents submitted (3 documents)
Address change, Shareholder change
WR.VI NS-REJ.KRS/20707/22/536
Filing documents submitted (9 documents)
Change in Section 6 (liquidation, bankruptcy or dissolution)
WR.VI NS-REJ.KRS/15853/25/995
Filing documents submitted (3 documents)
Trend: improving (-11 days/year)
Score
30/100
Late
5
Average delay
271 days
Max delay
858 days
On-time rate
17%
Latest reporting year
2024
Available years
6
Filing entries
6
Financial statement 2024
Financial statement 2022
Financial statement 2023
Financial statement 2021
Financial statement 2020
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Deepstributed Spółka z Ograniczoną Odpowiedzialnością
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
DEEPSTRIBUTED's board has 1 member.
